Drugmaker Bharat Biotech on Friday said it has scrapped agreements with two Brazilian companies amid controversy over a $324 million deal between the South American country and Bharat Biotech for the import of 20 million doses of the made-in-India COVID-19 vaccine Covaxin.
from Videos https://ift.tt/3y42CBF
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment